Home | Business News | Browse by Publication | P | PR Newswire

FDA Criminal Probe on Clarinex Approval, FDA Webview Reports.

Publication: PR Newswire
Publication Date: 02-APR-02
Format: Online - approximately 175 words
Delivery: Immediate Online Access

Article Excerpt
CAMP HILL, Pa. -- Suspected conflicts of interest in a private factory inspection that caused FDA to approve Schering-Plough's new allergy drug Clarinex in December are being investigated by the agency's Office of Criminal Investigation, reports Dickinson's FDA Webview (http://www.fdaweb.com/).

In an extensive report based on exclusive sources, the...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
Pennsylvania-American Water Company Reminds Customers to Guard Against..., April 02, 2002
NJHA's Comprehensive Resource Guide Helps Hospitals Navigate HIPAA Com..., April 02, 2002
Calpine Names Michael P. Thomas Senior Vice President., April 02, 2002
Calpine Names Joseph E. Ronan, Jr. Senior VP of Government & Regulator..., April 02, 2002
UMC and Micronas Collaborate on Low-cost, High-performance Flat-Panel ..., April 02, 2002

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.